Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients
出版年份 2018 全文链接
标题
Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer’s disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients
作者
关键词
Alzheimer’s disease, Memantine, Discontinuation, Efficacy, Meta-analysis, Meta-regression
出版物
BMC Geriatrics
Volume 18, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-07-24
DOI
10.1186/s12877-018-0857-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Systematic reviews with published protocols compared to those without: more effort, older search
- (2018) Katharina Allers et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Memantine and Brain Atrophy in Alzheimer's Disease: A 1-Year Randomized Controlled Trial
- (2018) David Wilkinson et al. JOURNAL OF ALZHEIMERS DISEASE
- The GERAS Study: A Prospective Observational Study of Costs and Resource Use in Community Dwellers with Alzheimer's Disease in Three European Countries – Study Design and Baseline Findings
- (2018) Anders Wimo et al. JOURNAL OF ALZHEIMERS DISEASE
- A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease
- (2018) Simona Gabriella Di Santo et al. JOURNAL OF ALZHEIMERS DISEASE
- Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
- (2018) Chen-Chen Tan et al. JOURNAL OF ALZHEIMERS DISEASE
- Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
- (2017) Lídia Blanco-Silvente et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Memantine for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis
- (2017) Taro Kishi et al. JOURNAL OF ALZHEIMERS DISEASE
- Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients
- (2017) M. Riera et al. PSYCHOPHARMACOLOGY
- Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study
- (2017) S. Bakchine et al. JOURNAL OF ALZHEIMERS DISEASE
- Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study
- (2016) Daniela Koller et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain
- (2016) Christina Abdel Shaheed et al. JAMA Internal Medicine
- EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease
- (2015) R. Schmidt et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients
- (2015) R. Cunill et al. PSYCHOPHARMACOLOGY
- Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study
- (2015) I. Abraha et al. BMJ-British Medical Journal
- Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study
- (2015) I. Abraha et al. BMJ-British Medical Journal
- Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer’s type in the US
- (2015) Catherine Saint-Laurent Thibault et al. JOURNAL OF MEDICAL ECONOMICS
- Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2015) Shinji Matsunaga et al. PLoS One
- Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors
- (2015) Anne Leinonen et al. PLoS One
- Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods
- (2014) Janus Christian Jakobsen et al. BMC Medical Research Methodology
- Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan
- (2014) Yu Nakamura et al. EXPERT OPINION ON PHARMACOTHERAPY
- Antidementia drug use among community-dwelling individuals with Alzheimer’s disease in Finland
- (2014) Heidi Taipale et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease
- (2014) Maurice W. Dysken et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis
- (2014) Jun Wang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence
- (2014) R Cunill et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
- (2013) George T. Grossberg et al. CNS DRUGS
- A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease
- (2013) Nathan Herrmann et al. INTERNATIONAL PSYCHOGERIATRICS
- Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study
- (2013) Bruno R. da Costa et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and Metaregression
- (2013) Shimon Schwartz et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of Heterogeneity (I2) Estimates and Their 95% Confidence Intervals in Large Meta-Analyses
- (2012) Kristian Thorlund et al. PLoS One
- Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
- (2012) Lucy E Farrimond et al. BMJ Open
- Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder
- (2011) Xavier Castells et al. CNS DRUGS
- GRADE guidelines: 7. Rating the quality of evidence—inconsistency
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review
- (2011) Juan Undurraga et al. NEUROPSYCHOPHARMACOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started